Researchers studied fungal infections caused by Aspergillus in Southern California from 2012 to 2023, examining over 10,000 patients. They found that species other than the commonly known A. fumigatus were actually more prevalent in clinical samples, particularly A. niger from skin and nail infections. Importantly, these non-fumigatus species showed seasonal patterns and some carry resistance to standard antifungal medications, suggesting doctors may need to adjust their treatment approaches for fungal infections.